NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11 | -78.8% | 16,233 | 0.0% | 0.00% | – |
| Q4 2022 | $52 | -99.9% | 16,233 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | -16.1% | 16,233 | 0.0% | 0.00% | – |
| Q2 2022 | $62,000 | +24.0% | 16,233 | +75.4% | 0.00% | – |
| Q1 2022 | $50,000 | -56.9% | 9,254 | +8.0% | 0.00% | – |
| Q4 2021 | $116,000 | -11.5% | 8,572 | +17.3% | 0.00% | – |
| Q3 2021 | $131,000 | -47.6% | 7,308 | -50.0% | 0.00% | – |
| Q2 2021 | $250,000 | -14.4% | 14,616 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $292,000 | -78.6% | 14,616 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,366,000 | +642.4% | 14,616 | +31.6% | 0.00% | 0.0% |
| Q3 2020 | $184,000 | -94.8% | 11,110 | -92.8% | 0.00% | -91.7% |
| Q2 2020 | $3,558,000 | -44.4% | 153,612 | -57.2% | 0.01% | -77.8% |
| Q1 2020 | $6,400,000 | -36.2% | 358,535 | -22.8% | 0.05% | -14.3% |
| Q4 2019 | $10,028,000 | +1268.1% | 464,605 | +1054.0% | 0.06% | +1160.0% |
| Q3 2019 | $733,000 | +38.3% | 40,260 | +170.2% | 0.01% | +25.0% |
| Q2 2019 | $530,000 | +6.0% | 14,898 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $500,000 | +27.6% | 14,898 | +24.9% | 0.00% | 0.0% |
| Q4 2018 | $392,000 | -44.8% | 11,925 | +2.4% | 0.00% | -20.0% |
| Q3 2018 | $710,000 | +24.8% | 11,645 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $569,000 | -61.4% | 11,645 | -52.9% | 0.01% | -61.5% |
| Q4 2017 | $1,476,000 | +81.1% | 24,716 | -47.9% | 0.01% | +30.0% |
| Q3 2016 | $815,000 | +161.2% | 47,413 | +116.3% | 0.01% | +150.0% |
| Q2 2016 | $312,000 | – | 21,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |